Oncotaxel

Product TA

Antineoplastic

Active Ingredient

Docetaxel

Route Of Administration

IV

Product type

Specialty


Product Details

Specialty

Oncology

Strength

20 mg

Product Form

Vial

Registration Number

DKI1629200649A1

Consumer Information Leaflet


Product Details

Specialty

Oncology

Strength

80 mg

Product Form

Vial

Registration Number

DKI1829200849A1

Consumer Information Leaflet


Additional products

Gemtavis

Product TA

Antineoplastic

Active Ingredient

Gemcitabine

Route Of Administration

IV

Product type

Specialty
View Product

Lezra

Product TA

Antineoplastic

Active Ingredient

Letrozole

Route Of Administration

Oral

Product type

Specialty
View Product

Page Last Updated: 30 August 2021